Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
5-9-1|ENU0-TH 0,ENU0-TH 0|Sequence:1, Age:-173,Type:ethylnitrosurea,Quantity:160,Unit:milligrams per kg animal,Application:Injection, intraperitoneal, Remarks:single injection to 80 day old fathers|69 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-1|ENU0-TH 0,ENU0-TH 0|Sequence:2, Age:100,Type:Th-227 citrate,Quantity:37,Unit:becquerels per g animal,Application:Injection, intraperitoneal, Remarks:single injection to F1 females|69 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-2|ENU0-TH 37,ENU0-TH 37|Sequence:1, Age:-173,Type:ethylnitrosurea,Quantity:160,Unit:milligrams per kg animal,Application:Injection, intraperitoneal, Remarks:single injection to 80 day old fathers|65 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-2|ENU0-TH 37,ENU0-TH 37|Sequence:2, Age:100,Type:Th-227 citrate,Quantity:37,Unit:becquerels per g animal,Application:Injection, intraperitoneal, Remarks:single injection to F1 females|65 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-3|ENU160-TH 0,ENU160-TH 0|Sequence:1, Age:-173,Type:ethylnitrosurea,Quantity:160,Unit:milligrams per kg animal,Application:Injection, intraperitoneal, Remarks:single injection to 80 day old fathers|69 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-3|ENU160-TH 0,ENU160-TH 0|Sequence:2, Age:100,Type:Th-227 citrate,Quantity:37,Unit:becquerels per g animal,Application:Injection, intraperitoneal, Remarks:single injection to F1 females|69 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-4|ENU160-TH 37,ENU160-TH 37|Sequence:1, Age:-173,Type:ethylnitrosurea,Quantity:160,Unit:milligrams per kg animal,Application:Injection, intraperitoneal, Remarks:single injection to 80 day old fathers|65 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
5-9-4|ENU160-TH 37,ENU160-TH 37|Sequence:2, Age:100,Type:Th-227 citrate,Quantity:37,Unit:becquerels per g animal,Application:Injection, intraperitoneal, Remarks:single injection to F1 females|65 (0 in ERA)|Mouse|Mouse, C3Hx102/F1|Both|Preconception|fathers treated  ethylonitrosourea, F1 females received Th-227|No information on individuals available for this study
		
